Skills this job asks for
LeadershipMachine learningTranslationData engineeringRecruitmentDeep learning
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles4 certified filings for “Associate Director, Precision Medicine” (Medical Scientists, Except Epidemiologists) in MA: $179k–$260k, median $215k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 4 certified filings for “Associate Director, Precision Medicine” (Medical Scientists, Except Epidemiologists) in MA: $179k–$260k, median $215k. Most were filed at wage level II (75%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Director, Biologics AI
About the Role
We are seeking an experienced and visionary Director, Biologics AI to lead Biologics AI innovation at AstraZeneca’s US R&D center in Cambridge, MA. This is a high‑impact scientific leadership role accountable for defining and executing the AI strategy that integrates state‑of‑the‑art machine learning with wet‑lab discovery to accelerate biologics engineering and enable next‑generation biotherapeutics. You will set technical direction, own delivery across multiple programs, and shape data generation at scale—working across computational and experimental functions and with global partners to translate AI into robust, reproducible advances in discovery.
Key Responsibilities
• Strategic leadership and vision: Define and drive the AI strategy for biologics discovery and engineering, setting priorities and roadmaps that integrate AI and wet‑lab capabilities and deliver measurable impact on pipeline goals.
• Program ownership: Lead multiple cross‑functional discovery initiatives from problem framing through deployment, ensuring rapid translation of computational insights into experimental design and decision‑making.
• Advanced ML innovation: Architect, develop, and guide application of cutting‑edge models—protein language models, structure‑informed and geometric methods, de novo/protein design, and multi‑modal learning that fuses sequence, structure, and biological activity data—to solve high‑value scientific problems.
• AI–wet‑lab integration at scale: Establish closed‑loop design–build–test–learn workflows with experimental teams, formalizing feedback cycles, uncertainty quantification, and active learning to improve model reliability and throughput.
• Data strategy and governance: Set standards for high‑quality data generation, curation, and metadata; partner with wet‑lab leaders to design assays and campaigns that maximize ML utility and reproducibility; influence data platform evolution in collaboration with informatics and engineering.
• End‑to‑end ML lifecycle leadership: Oversee and improve processes across data pipelines, model development, validation, deployment, monitoring, and continuous improvement, including best practices for reproducibility, documentation, and scientific rigor.
• Technical mentorship and team development: Mentor and upskill scientists across AI/ML and experimental domains; provide day‑to‑day technical guidance and contribute to recruitment and development of a high‑performing team.
• Stakeholder influence and communication: Communicate strategy, progress, risk, and scientific insights to senior stakeholders; influence portfolio decisions and advocate for AI‑enabled approaches internally and with external partners.
• External scientific leadership: Drive publications, patents, and external visibility; represent AstraZeneca in collaborations and at scientific venues; evaluate and integrate emerging methods and tools.
Required Qualifications
• Education and experience: PhD in computer science, machine learning, bioinformatics, computational biology, physics, chemistry, mathematics, engineering, or a related quantitative field, with typically 8+ years of relevant post‑degree experience in academia and/or industry; or a Master’s with 12+ years of relevant experience.
• Domain impact in biologics AI: Demonstrated track record applying AI/ML to proteins, antibodies, or related biologics, with clear examples of methods translated into experimental outcomes, platform capabilities, or pipeline decisions.
• Deep technical expertise: Hands‑on leadership in developing and deploying advanced ML (deep learning, generative models, structure‑aware and geometric methods, sequence/structure multi‑modal models) for protein sequence modeling, structure‑informed prediction,
Apply on employer site ↗